NHS NEL
Demonstration Formulary
Demonstration Formulary
5 Infections
This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines
Summary of antimicrobial prescribing guidance - managing common infections
05-03-04 Influenza
| Oseltamivir |
|
First Choice
|
|
 UKMI Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza? TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza TA168: Amantadine, oseltamivir and zanamivir for the treatment of influenza PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza |
|
-For Primary Care- Green only during Flu season and on authorisation by NHS England/Department of Health & Social Care or via commissioned service for out of season supply| Oseltamivir Tamiflu® |
|
First Choice
|
|
|
UKMI Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza? TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza TA168: Amantadine, oseltamivir and zanamivir for the treatment of influenza PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza |
|
|
| Zanamivir Relenza® |
|
Second Choice
|
|
|
UKM I Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza? TA 168: Amantadine, oseltamivir and zanamivir for the treatment of influenza TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza |
|
|
Links
- NICE 2008: Influenza prophylaxis
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary)
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza
- PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza
- Summary of antimicrobial prescribing guidance - managing common infections
- TA 168: Amantadine, oseltamivir and zanamivir for the treatment of influenza
- TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
- TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
- TA158: Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
- TA168: Amantadine, oseltamivir and zanamivir for the treatment of influenza
- TA168: Amantadine, oseltamivir and zanamivir for the treatment of influenza
- UKM I Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza?
- UKMI Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza?
- UKMI Q&A: Oseltamivir or zanamivir – can mothers breastfeed after treatment for influenza?